Colon Cancer
Almac Publishes Stage II Colon Cancer Recurrence Signature in the Journal of Clinical Oncology
Published in Cancer Weekly, November 22nd, 2011
The article entitled "Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue" gives detail on the development and validation of a prognostic gene signature in Stage II colon cancer.
Colon Cancer is the third most common cancer in the United States with over 101,000 cases diagnosed per year.
Current clinical guidelines for patients presenting with stage II colon...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2011-11-22)
More Articles from Cancer Weekly
- Testicular Cancer
Data from J. Heinzelbecker et al Provide New Insights into Testicular Cancer - Bioscience
Data from National Yang Ming University Provide New Insights into Bioscience - Lung Cancer
Data from Pontifical Catholic University Advance Knowledge in Lung Cancer - Indicators and Reagents
Data from University of Michigan Advance Knowledge in Indicators and Reagents - Colon Cancer
Data on Colon Cancer Published by Researchers at University of North Carolina - Epidemiology
Data on Epidemiology Described by Researchers at Beth Israel Deaconess Medical Center - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
